Companies /Healthcare

Baxter International Inc

NYSE: BAX Medical Instruments & Supplies

Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
60%
EPS beat rate
+12.58%
Avg. EPS surprise
Consecutive EPS beats
BAX vs Market · 30-day return after each reportBAXS&P 500
−5%0%+5%+10%+11.1%+1.3%Q2 25−1.7%+0.3%Q3 25−5.8%−1.5%Q4 25+6.3%+5.7%Q1 26−2.8%+3.4%Q2 26
−5%0%+5%+10%Q2 25Q3 25Q4 25Q1 26Q2 26
BAX EPS Trend · estimate vs actualEstimateActual
$0.00$0.20$0.40$0.60$0.61$0.59Q2 25$0.60$0.69Q3 25$0.54$0.44Q4 25$0.31$0.36Q1 26$0.37$0.56Q2 26
$0.00$0.20$0.40$0.60Q2 25Q3 25Q4 25Q1 26Q2 26
BAX Revenue Trend · estimate vs actualEstimateActual
$0$900.0M$1.8B$2.7B$2.8B$2.8BQ2 25$2.9B$2.8BQ3 25$2.8B$3.0BQ4 25$2.6B$2.7BQ1 26$2.8B$3.0BQ2 26
$0$900.0M$1.8B$2.7BQ2 25Q3 25Q4 25Q1 26Q2 26

Quarter by Quarter

Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $0.56 est. $0.37 +52.51% $3.0B est. $2.8B +5.88%
Q1 2026 $0.36 est. $0.31 +15.90% $2.7B est. $2.6B +3.27%
Q4 2025 $0.44 est. $0.54 −17.80% $3.0B est. $2.8B +5.28%
Q3 2025 $0.69 est. $0.60 +15.40% $2.8B est. $2.9B −1.47%
Q2 2025 $0.59 est. $0.61 −3.12% $2.8B est. $2.8B −0.45%

Figures from SEC filings and company reports. Not investment advice.